Literature DB >> 17435116

Coccidioidomycosis in the U.S. Military: a review.

Nancy F Crum-Cianflone1.   

Abstract

Coccidioidomycosis has had an impact on the military since the discovery of the causative agent, Coccidioides immitis, over a century ago. The first reports of Coccidioides outbreaks affecting U.S. military personnel were reported by Smith and others during World War II. Since that time, numerous outbreaks and sporadic cases have occurred, affecting both the health and readiness of our armed forces. This article summarizes the impact of Coccidioides sp. on our military troops with a review of the literature, a description of the experience at a tertiary referral hospital treating the disease, and a synopsis of incidence studies conducted at bases in the southwestern United States. The substantial effect that coccidioidomycosis has had on the military supports the development of both newer and more effective treatments as well as a Valley Fever vaccine for prevention of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435116     DOI: 10.1196/annals.1406.001

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

2.  Coccidioidomycosis Outbreaks, United States and Worldwide, 1940-2015.

Authors:  Michael Freedman; Brendan R Jackson; Orion McCotter; Kaitlin Benedict
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

Review 3.  Coccidioidomycosis: A Contemporary Review.

Authors:  Nancy F Crum
Journal:  Infect Dis Ther       Date:  2022-03-01

4.  Coccidioidomycosis Seroincidence and Risk among Military Personnel, Naval Air Station Lemoore, San Joaquin Valley, California, USA1.

Authors:  Graham C Ellis; Charlotte A Lanteri; Hsing-Chuan Hsieh; Paul C F Graf; Gabriel Pineda; Nancy F Crum-Cianflone; Catherine M Berjohn; Terrel Sanders; Ryan C Maves; Robert Deiss
Journal:  Emerg Infect Dis       Date:  2022-09       Impact factor: 16.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.